Merck (MRK) Over-Hyped in Hep C, Says Wells Fargo (GILD) (ABBV)
Go back to Merck (MRK) Over-Hyped in Hep C, Says Wells Fargo (GILD) (ABBV)| AbbVie (NYSE: ABBV) | Delayed: 262.23 -4.05 (1.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $266.28 | 52 Week High | $68.12 | |||
| Open | $265.45 | 52 Week Low | $50.71 | |||
| Day High | $268.93 | P/E | 56.88 | |||
| Day Low | $261.52 | EPS | $4.61 | |||
| Volume | 635,192 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 149.14 -3.07 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.21 | 52 Week High | $108.63 | |||
| Open | $150.18 | 52 Week Low | $71.39 | |||
| Day High | $152.63 | P/E | 82.40 | |||
| Day Low | $149.02 | EPS | $1.81 | |||
| Volume | 799,889 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 146.40 -2.29 (1.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.69 | 52 Week High | $65.46 | |||
| Open | $148.17 | 52 Week Low | $47.97 | |||
| Day High | $150.36 | P/E | 99.59 | |||
| Day Low | $146.09 | EPS | $1.47 | |||
| Volume | 1,184,100 | |||||
